Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation

Cardiovascular Research

Volumn 71, Issue 3, 2006, Pages 596-605

  Grote, Karsten ^a   Ortmann, Magdalene ^a   Salguero, Gustavo ^a   Doerries, Carola ^a   Landmesser, Ulf ^a   Luchtefeld, Maren ^a   Brandes, Ralf P ^b   Gwinner, Wilfried ^a   Tschernig, Thomas ^a   Brabant, Ernst Georg ^a   Klos, Andreas ^a   Schaefer, Arnd ^a   Drexler, Helmut ^a   Schieffer, Bernhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Blood pressure; NAD(P)H oxidase; p47phox; Reactive oxygen species; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE; LEUCINE; LUCIGENIN; OXYGEN RADICAL; PROTEIN P47; PROTEIN SUBUNIT; QUINAPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; TELMISARTAN; TEMPOL; AMINE OXIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; NEUTROPHIL CYTOSOLIC FACTOR 1; REACTIVE OXYGEN METABOLITE;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRON; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PUERPERIUM; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SAMPLE; SYSTOLIC BLOOD PRESSURE; WILD TYPE; ANIMAL; BLOOD; BLOOD PRESSURE; C57BL MOUSE; CARDIOMEGALY; DRUG EFFECT; KIDNEY; METABOLISM; METHODOLOGY; MOUSE MUTANT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPIN LABELING; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CARDIOMEGALY; CYCLIC N-OXIDES; ENDOTHELIUM, VASCULAR; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENIN; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPIN LABELS;

EID: 33746276979     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.05.020     Document Type: Article

References (39)

1. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89 (2002) 3A-9A
2. Dzau V.J. Significance of the vascular renin-angiotensin pathway. Hypertension 8 (1986) 553-559
3. Griendling K.K., and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91 (2000) 21-27
4. Touyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 37 (2004) 1263-1273
5. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 (1996) 1916-1923
6. Bendall J.K., Cave A.C., Heymes C., Gall N., and Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105 (2002) 293-296
7. Wilcox C.S. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?. Am J Physiol Regul Integr Comp Physiol 289 (2005) 913-935
8. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) 277-297
9. Brandes R.P., and Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65 (2005) 16-27
10. Babior B.M. Related Articles, NADPH oxidase: an update. Blood 93 (1999) 1464-1476
11. Touyz R.M., Yao G., and Schiffrin E.L. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23 (2003) 981-987
12. Grote K., Flach I., Luchtefeld M., Akin E., Holland S.M., Drexler H., et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92 (2003) e80-e86
13. Hsich E., Segal B.H., Pagano P.J., Rey F.E., Paigen B., Deleonardis J., et al. Vascular effects following homozygous disruption of p47(phox): an essential component of NADPH oxidase. Circulation 101 (2000) 1234-1236
14. Lavigne M.C., Malech H.L., Holland S.M., and Leto TL. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 104 (2001) 79-84
15. Li J.M., Mullen A.M., Yun S., Wientjes F., Brouns G.Y., Thrasher A.J., et al. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 90 (2002) 143-150
16. Li J.M., Wheatcroft S., Fan L.M., Kearney M.T., and Shah A.M. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2-production, vascular tone, and mitogen-activated protein kinase activation. Circulation 109 (2004) 1307-1313
17. Barry-Lane P.A., Patterson C., van der Merwe M., Hu Z., Holland S.M., Yeh E.T., et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108 (2001) 1513-1522
18. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin. Hypertension 40 (2002) 511-515
19. Wang H.D., Xu S., Johns D.G., Du Y., Quinn M.T., Cayatte A.J., et al. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88 (2001) 947-953
20. Jackson S.H., Gallin J.I., and Holland S.M. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182 (1995) 751-758
21. Schaefer A., Klein G., Brand B., Lippolt P., Drexler H., and Meyer G.P. Evaluation of left ventricular diastolic function by pulsed Doppler tissue imaging in mice. J Am Soc Echocardiogr 16 (2003) 1144-1149
22. Rosenkranz A.R., Schmaldienst S., Stuhlmeier K.M., Chen W., Knapp W., and Zlabinger G.J. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate. J Immunol Methods 156 (1992) 39-45
23. Gwinner W., Landmesser U., Brandes R.P., Kubat B., Plasger J., Eberhard O., et al. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 8 (1997) 1722-1731
24. Spiekermann S., Landmesser U., Dikalov S., Bredt M., Gamez G., Tatge H., et al. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107 (2003) 1383-1389
25. Vaziri N.D., Ding Y., and Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 298 (2001) 679-685
26. Jandeleit-Dahm K., Lassila M., Davis B.J., Candido R., Johnston C.I., Allen T.J., et al. Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice. J Hypertens 23 (2005) 2071-2082
27. 1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain. Clin Exp Hypertens 20 (1998) 205-221
28. McPhail L.C., Shirley P.S., Clayton C.C., and Snyderman R. Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor. J Clin Invest 75 (1985) 1735-1739
29. Bendall J.K., Cave A.C., Heymes C., Gall N., and Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105 (2002) 293-296
30. Wilcox C.S. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4 (2002) 160-166
31. Meng S., Cason G.W., Gannon A.W., Racusen L.C., and Manning Jr. R.D. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41 (2003) 1346-1352
32. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 (2001) 1107-1111
33. Rey F.E., Cifuentes M.E., Kiarash A., Quinn M.T., and Pagano P.J. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89 (2001) 408-414
34. Brandes R.P., Miller F.J., Beer S., Haendeler J., Hoffmann J., Ha T., et al. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med 32 (2002) 1116-1122
35. Kobori H., Nishiyama A., Abe Y., and Navar L.G. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41 (2003) 592-597
36. Kobori H., and Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun 315 (2004) 746-750
37. Xu Y.C., Wu R.F., Gu Y., Yang Y.S., Yang M.C., Nwariaku F.E., et al. Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. J Biol Chem 277 (2002) 28051-28057
38. Gu Y., Xu Y.C., Wu R.F., Nwariaku F.E., Souza R.F., Flores S.C., et al. p47phox participates in activation of RelA in endothelial cells. J Biol Chem 278 (2003) 17210-17217
39. Li J., and Brasier A.R. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10 (1996) 252-264